| Date | Title | Description |
| 24.10.2024 | Redsense Medical to focus on core growth areas, discontinuing trading on OTCQX | Redsense Medical to focus on core growth areas, discontinuing trading on OTCQX
Thu, Oct 24, 2024 15:25 CET Report this content
Redsense Medical AB has decided not to renew its agreement with OTC Markets Group after the current term, which e... |
| 16.10.2024 | Nomination committee appointed for the 2025 Annual General Meeting in Redsense Medical AB | Nomination committee appointed for the 2025 Annual General Meeting in Redsense Medical AB
Wed, Oct 16, 2024 16:33 CET Report this content
A nomination committee has been established ahead of the 2025 annual general meeting in Redsense Medic... |
| 24.09.2024 | Redsense Medical: A New Era Begins with Leadership Changes | Redsense Medical AB is turning a new page. The company has appointed Sebastien Bollue as its new CEO, effective October 1, 2024. This marks a significant shift in leadership for a firm that has carved a niche in the dialysis safety sector. ... |
| 24.09.2024 | Redsense Medical AB (publ) appoints a new CEO | Redsense Medical AB (publ) appoints a new CEO
Tue, Sep 24, 2024 09:00 CET Report this content
Redsense Medical AB is pleased to announce that Sebastien Bollue takes over as the company's new CEO as of October 1st, 2024. Sebastien Bollue has... |
| 21.09.2024 | Member of the board of Redsense Medical AB resigns | Member of the board of Redsense Medical AB resigns
Sat, Sep 21, 2024 16:59 CET Report this content
Redsense Medical AB (publ), a leader in innovations for safety and monitoring of the venous access in dialysis treatment, announces that boar... |
| 16.09.2024 | Chairman of the board of Redsense Medical AB resigns - Acting chairman of the board appointed | Chairman of the board of Redsense Medical AB resigns - Acting chairman of the board appointed
Mon, Sep 16, 2024 08:30 CET Report this content
Redsense Medical AB (publ), a leader in innovations for safety and monitoring of the vein needle i... |
| 29.08.2024 | Interim Report Q2 – January – June, 2024 Redsense Medical AB (publ.) | Interim Report Q2 – January – June, 2024 Redsense Medical AB (publ.)
Thu, Aug 29, 2024 08:30 CET Report this content
April – June 2024 Net sales amounted to kSEK 8,749 (4,831) Operating profit, EBIT amounted to kSEK 613 (-3,045). Result aft... |
| 15.07.2024 | Major shareholding notification | Major shareholding notification
Mon, Jul 15, 2024 11:30 CET Report this content
Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 25 percent shareholding.
Through a recent directed issue, ShapeQ Gm... |
| 28.06.2024 | Redsense has secured a new order worth MSEK 6.99 | Redsense has secured a new order worth MSEK 6.99
Fri, Jun 28, 2024 18:06 CET Report this content
Redsense Medical has received a new order valued at MSEK 6.99 from one of its U.S. distributors This order reflects a step in our strategy to b... |
| 25.06.2024 | Major shareholding notification | Major shareholding notification
Tue, Jun 25, 2024 14:36 CET Report this content
Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 20 percent shareholding.
Through a recent directed issue, ShapeQ Gm... |
| 31.05.2024 | The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of MSEK 7,5. | The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of MSEK 7,5.
Fri, May 31, 2024 20:45 CET Report this content
The Board of Directors in Redsense Medical AB (publ) ("Redsense" or the... |
| 27.05.2024 | The CEO leaves Redsense Medical AB | The CEO leaves Redsense Medical AB
Mon, May 27, 2024 17:13 CET Report this content
The Board of Directors of Redsense Medical AB and Pontus Nobréus, CEO since Aug 2022, have reached a mutual agreement that Pontus Nobréus will leave his posi... |
| 23.05.2024 | Major shareholding notification | Major shareholding notification
Thu, May 23, 2024 09:06 CET Report this content
Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 10 percent shareholding.
Through a recent share purchase, ShapeQ Gm... |
| 22.05.2024 | Major shareholding notification | Major shareholding notification
Wed, May 22, 2024 18:01 CET Report this content
Redsense Medical AB hereby announces that Discover Capital GmbH has sold all shares in Redsense Medical AB corresponding to 750 000 shares. Prior to the sales, ... |
| 15.05.2024 | Redsense Medical presents at Sedermeradagen Stockholm 2024 | Redsense Medical presents at Sedermeradagen Stockholm 2024
Wed, May 15, 2024 15:07 CET Report this content
Sedermera Corporate Finance will once again host Sedermeradagen on May 22, 2024. The event will take place at Hotel At Six in Stockho... |
| 13.05.2024 | Redsense Medical Spotlight presentation at the 61[st] ERA Congress in Stockholm | Redsense Medical Spotlight presentation at the 61[st] ERA Congress in Stockholm
Mon, May 13, 2024 11:06 CET Report this content
Redsense Medical will exhibit at the 61st ERA (European Renal Association) Congress in Stockholm, May 23-26, 202... |
| 08.05.2024 | Interim Report Q1 – January – March, 2024 Redsense Medical AB (publ.) | Interim Report Q1 – January – March, 2024 Redsense Medical AB (publ.)
Wed, May 08, 2024 08:30 CET Report this content
January – March 2024 Net sales amounted to kSEK 1,711 (6,824)
Operating loss, EBIT amounted to kSEK 2,656 (104).
Result af... |
| 24.04.2024 | Redsense Medical welcomes new investment from ShapeQ to accelerate growth | Redsense Medical welcomes new investment from ShapeQ to accelerate growth
Wed, Apr 24, 2024 17:45 CET Report this content
Today Redsense Medical has announced a direct share issue to ShapeQ and the press release can be found at https://reds... |
| 24.04.2024 | The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8. | The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8.
Wed, Apr 24, 2024 17:01 CET Report this content
The Board of Directors in Redsense Medical AB (publ) ("Redsens... |
| 19.04.2024 | Redsense Medical attending Home Dialysis Congress in Germany | Redsense Medical attending Home Dialysis Congress in Germany
Fri, Apr 19, 2024 16:24 CET Report this content
Redsense Medical will be participating and exhibiting at the 14th Cologne Home Dialysis Congress of the KfH. The event takes places... |
| 14.03.2024 | Home Dialysis Risk Prevention Act addressed in House Committee on Ways and Means Hearing | Home Dialysis Risk Prevention Act addressed in House Committee on Ways and Means Hearing
Thu, Mar 14, 2024 16:30 CET Report this content
On March 12, 2024, the House Committee on Ways and Means Chairman Jason Smith (MO-08) held a Hearing to... |
| 08.03.2024 | Redsense Medical attending US dialysis conferences this spring | Redsense Medical attending US dialysis conferences this spring
Fri, Mar 08, 2024 10:00 CET Report this content
Redsense Medical will be exhibiting at several US dialysis conferences this March and April. These events are effective ways for ... |
| 09.01.2024 | Change in the Nomination Committee of Redsense Medical AB | Change in the Nomination Committee of Redsense Medical AB
Tue, Jan 09, 2024 10:41 CET Report this content
The Nomination Committee of Redsense Medical AB was announced in a press release on October 26, 2023 and Patrik Byhmer was appointed b... |
| 26.10.2023 | Nomination Committee appointed for the 2024 Annual General Meeting of Redsense Medical AB | Nomination Committee appointed for the 2024 Annual General Meeting of Redsense Medical AB
Thu, Oct 26, 2023 09:50 CET Report this content
A Nomination Committee has been established for the 2024 Annual General Meeting of Redsense Medical AB... |
| 14.07.2023 | Health
Health | ‘It was a bloodbath’: Rare dialysis complication can kill, and more could be done to stop it | Brett Kelman | (TNS) KFF Health News
Nieltje Gedney was half-asleep in her West Virginia home, watching murder mysteries over the hum of a bedside hemodialysis machine, when she felt something warm and wet in her armpit.
A needle inserted i... |
| 06.07.2023 | "It was a bloodbath": Rare dialysis complication can kill patients in minutes — and more could be done to stop it | Nieltje Gedney was half-asleep in her West Virginia home, watching murder mysteries over the hum of a bedside hemodialysis machine, when she felt something warm and wet in her armpit.
A needle inserted into her arm had fallen loose, breakin... |
| 15.11.2022 | Correction: Consolidated cash flow analysis interim report January-September 2022 Redsense Medical AB (publ) | Correction: Consolidated cash flow analysis interim report January-September 2022 Redsense Medical AB (publ)
Tue, Nov 15, 2022 15:42 CET Report this content
The correction refers to the consolidated cash flow analysis on page 13 of the inte... |
| 16.09.2022 | Redsense presents at Aktiedagen Lund | Redsense presents at Aktiedagen Lund
Fri, Sep 16, 2022 11:59 CET Report this content
Monday, September 26, 2022, Redsense participates in Aktiespararna’s event Aktiedagen Lund. Pontus Nobréus, CEO, will present the company and answer your q... |
| 15.09.2022 | New article brings forward support for home dialysis in connection with comorbidities | New article brings forward support for home dialysis in connection with comorbidities
Thu, Sep 15, 2022 10:21 CET Report this content
Redsense Medical notes that a new scientific article is presenting emerging evidence that strengthens the ... |
| 29.08.2022 | Interim Report Q2 – April – June, 2022 Redsense Medical AB (publ) | Interim Report Q2 – April – June, 2022 Redsense Medical AB (publ)
Mon, Aug 29, 2022 08:45 CET Report this content
April – June 2022 Net sales amounted to kSEK 1,927 (1,479), an increase by 30.3 percent. Operating loss, EBIT amounted to kSEK... |
| 06.07.2022 | Redsense announces CEO succession date | Redsense announces CEO succession date
Wed, Jul 06, 2022 12:46 CET Report this content
Redsense Medical announces that newly appointed Pontus Nobréus will take over as CEO of the Company starting the 1st of August 2022. Outgoing CEO Patrik ... |
| 11.05.2022 | Redsense to exhibit on the 59[th] ERA-EDTA congress | Redsense to exhibit on the 59[th] ERA-EDTA congress
Wed, May 11, 2022 11:19 CET Report this content
Redsense Medical announces that the company will exhibit on this year’s ERA-EDTA conference in Paris, May 19-22.
The European Renal Associat... |
| 02.05.2022 | Redsense announces new CEO | Redsense announces new CEO
Mon, May 02, 2022 12:50 CET Report this content
Redsense Medical announces that the highly experienced global life science leader Pontus Nobréus is appointed new CEO. Nobréus combines a track record of driving sal... |
| 02.05.2022 | Interim Report Q1 – January – March, 2022 Redsense Medical AB (publ) | Interim Report Q1 – January – March, 2022 Redsense Medical AB (publ)
Mon, May 02, 2022 08:30 CET Report this content
January – March 2022 Net sales amounted to kSEK 3,127 (685), an increase by 356 percent. Operating loss, EBIT amounted to k... |
| 23.03.2022 | New MHRA Guidance acknowledges the need to monitor for VND | New MHRA Guidance acknowledges the need to monitor for VND
Wed, Mar 23, 2022 09:57 CET Report this content
Redsense Medical announces today that the UK Medicines & Healthcare Products Regulatory Agency (MHRA) has issued a new dialysis g... |
| 16.03.2022 | Redsense participates in US congress briefing on VND | Redsense participates in US congress briefing on VND
Wed, Mar 16, 2022 08:01 CET Report this content
Redsense Medical successfully participated in a virtual briefing about venous needle dislodgement (VND) for US congress on March 14, 2022. ... |
| 28.02.2022 | Year-end Report 2021 Redsense Medical AB (publ) | Year-end Report 2021 Redsense Medical AB (publ)
Mon, Feb 28, 2022 08:30 CET Report this content
October – December 2021 Net sales amounted to kSEK 4,059 (2,228), an increase by 82 percent. Operating loss, EBIT amounted to kSEK 3,073 (4,716)... |
| 30.12.2021 | Redsense registered with the MHRA for continued access to the Great Britain market | Redsense registered with the MHRA for continued access to the Great Britain market Thu, Dec 30, 2021 16:00 CET
Redsense Medical announces today that the UK Medicines & Healthcare products Regulatory Agency (MHRA), the executive agency r... |
| 18.11.2021 | Redsense receives order from Christus Spohn Hospital in the United States | Redsense receives order from Christus Spohn Hospital in the United States Thu, Nov 18, 2021 10:10 CET
Redsense Medical AB has received an order for 22 Redsense Alarms from the CHRISTUS Spohn Hospital Shoreline in Corpus Christi, Texas – the... |
| 09.11.2021 | Interim Report Q3 – July – September, 2021 Redsense Medical AB (publ) | Interim Report Q3 – July – September, 2021 Redsense Medical AB (publ) Tue, Nov 09, 2021 08:30 CET
July – September 2021 Net sales amounted to kSEK 3,566 (2,107), a 69 percent increase compared with the corresponding period in 2020. Profit o... |
| 13.10.2021 | Redsense receives first order from Canada | Redsense receives first order from Canada Wed, Oct 13, 2021 11:01 CET
Redsense Medical AB announces today that the Company has received its first order from Canada. The news follows the recent conclusion of a new distributor agreement for t... |
| 24.08.2021 | Interim Report Q2 – April – June, 2021 Redsense Medical AB (publ) | Interim Report Q2 – April – June, 2021 Redsense Medical AB (publ) Tue, Aug 24, 2021 08:30 CET
Second quarter,
1 April – 30 June 2021
The Redsense Group Net sales amounted to kSEK 1,059 (5,292), an 80 percent decrease compared with the corre... |
| 16.08.2021 | Redsense signs new distributor agreement for Canada and Bermuda with CardioMed Supplies Inc. | Redsense signs new distributor agreement for Canada and Bermuda with CardioMed Supplies Inc. Mon, Aug 16, 2021 09:04 CET
Redsense Medical AB announces today that a new distributor agreement has been concluded with the Ontario-based company ... |
